论文部分内容阅读
肾脏疾病的发展过程与血液的凝血抗凝过程密切相关。在凝血反应中,组织因子(TF)起着关键作用,而组织因子途径抑制物(TFPI)是TF诱导的凝血过程的重要负性调节物。我们于2001年3月至2002年3月测定了34例慢性肾脏病患者血浆TF、TFPI的活性,探讨其临床意义,报告如下。对象与方法1.
The development of kidney disease is closely related to the blood coagulation and anticoagulation process. Tissue factor (TF) plays a key role in the coagulation response, while tissue factor pathway inhibitor (TFPI) is an important negative regulator of TF-induced coagulation. We measured the plasma TF and TFPI activity in 34 patients with chronic kidney disease from March 2001 to March 2002 and discussed their clinical significance, the report is as follows. Objects and methods 1.